Sekar Kathiresan, CEO: Verve Therapeutics VERV Sell · Filed 25/04/03

Trade details

Type: Insider sale
Amount: $40,761.3
Shares · price: 9,822 sh · $4.15 a share
Held after: 346,686 sh
Stock: Verve Therapeutics VERV
Person: Sekar KathiresanCEO
Trade date: 25/04/02
Filed: 25/04/03
Days to filing: 1 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Verve Therapeutics trades, last 26 weeks

What else happened in Verve Therapeutics around then

Filed or reported within 30 days of the trade day · 25/03/03~25/05/02

Sekar Kathiresan's recent trades

Sekar KathiresanDirector
Planned saleRelay Therapeutics
Planned sale
Relay Therapeutics
RLAY
$826.5K
42,225 sh
$826.5K
Filed 08/04
Traded 08/04
Sekar KathiresanDirector
Planned saleRelay Therapeutics
Planned sale
Relay Therapeutics
RLAY
$563.6K
30,000 sh
$563.6K
Filed 07/31
Traded 07/31
Sekar KathiresanDirector
Planned saleRelay Therapeutics
Planned sale
Relay Therapeutics
RLAY
$594.4K
30,000 sh
$594.4K
Filed 07/21
Traded 07/21
Sekar KathiresanDirector
Planned saleRelay Therapeutics
Planned sale
Relay Therapeutics
RLAY
$1.3M
66,055 sh
$1.3M
Filed 07/20
Traded 07/20
Sekar KathiresanDirector
Planned saleMaze Therapeutics
Planned sale
Maze Therapeutics
MAZE
$1.2M
29,772 sh
$1.2M
Filed 01/16
Traded 01/16